Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Sampling During Night Shifts – V 2.0

Posted on By


Biosimilars: SOP for Sampling During Night Shifts – V 2.0


Standard Operating Procedure for Sampling During Night Shifts in Biosimilar Upstream Manufacturing

Department Biosimilars
SOP No. SOP/BS/110/2025
Supersedes SOP/BS/110/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for aseptic, accurate, and timely sampling during night shifts from upstream bioreactor systems in biosimilar manufacturing, ensuring sample integrity and traceability.

2. Scope

This SOP applies to all biosimilar upstream processing units where samples are collected between 18:00 and 06:00 hours from bioreactors, seed flasks, or media tanks for in-process testing.

3. Responsibilities

  • Night Shift Operator: Perform aseptic sampling, labeling, and documentation.
  • Night Shift Supervisor: Review sampling logs and approve any deviations.
  • QC: Receive and analyze samples upon arrival, report any anomalies.

4. Accountability

The Production Manager is accountable for ensuring that night shift sampling complies with cGMP, data integrity, and in-process control requirements.

5. Procedure

5.1 Preparation Before Sampling

  1. Confirm sampling schedule in the approved Batch Manufacturing Record (BMR).
  2. Sanitize gloves, sampling port, and containers with 70% IPA before sampling.
  3. Verify ID and calibration status of pH probe, DO probe, and temperature sensors.

5.2 Sampling Execution

  1. Wear appropriate PPE and enter the classified area according to gowning procedures.
  2. Label sterile sample containers with:
    • Batch number
    • Date and time of sampling
    • Sample type and volume
    • Operator initials
  3. Use aseptic sampling valve or septum to collect:
    • 10–50 mL depending on test
    • Avoid drawing air into the line
  4. Immediately cap and store samples at 2–8°C in designated transfer box.

5.3 Sample Transport and Handover

  1. Transfer samples to the QC sample drop-off refrigerator by 06:30 hrs.
  2. Fill Annexure-2: Night Sampling Transfer Log and obtain security sign-off.

5.4 Documentation and Traceability

  1. Log all sampling activities in Annexure-1: Night Sampling Log Sheet.
  2. Note any delays, abnormalities, or sample rejections and escalate to QA if required.

5.5 Deviation Handling

  1. If sampling time deviates by more than ±30 minutes from scheduled time, raise a deviation record as per deviation SOP.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QC: Quality Control
  • PPE: Personal Protective Equipment
  • IPA: Isopropyl Alcohol

7. Documents

  1. Night Sampling Log Sheet – Annexure-1
  2. Night Sampling Transfer Log – Annexure-2

8. References

  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Night Sampling Log Sheet

Date Time Sample Type Volume Bioreactor ID Initials Remarks
04/05/2025 03:00 In-process 20 mL BR-12 Sunita Reddy NA

Annexure-2: Night Sampling Transfer Log

Date Time No. of Samples Delivered By Received By (Security) Remarks
04/05/2025 06:20 3 Ajay Verma Security-02 QC Notified

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added sample transport log and deviation handling clause Audit recommendation
See also  Biosimilars: SOP for Inoculation of Bioreactors - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Recording and Reporting In-Process Control Data – V 2.0
Next Post: Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version